Hudson Bay Capital Management
RKDA icon

Hudson Bay Capital Management’s Arcadia Biosciences RKDA Stock Holding History

Hudson Bay Capital Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,763
Closed -$4.14M – 951
2018
Q1 		$4.14M Buy
+3,763
New +$1.69M 0.09% 273

Other funds holding RKDA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management's RKDA Position: Q2 2018 in Review

Hudson Bay Capital Management sold out of Arcadia Biosciences (RKDA) in Q2 2018, closing a stake of 3,763 shares — an estimated $4.14M sold.

Hudson Bay Capital Management first reported a position in RKDA in Q1 2018 and held it in 1 quarter. The position peaked at $4.14M in Q1 2018. 13 funds tracked by Wall St. Rank hold RKDA as of Q2 2018.

  • Hudson Bay Capital Management reported no remaining Arcadia Biosciences position as of Q2 2018 after selling out during the quarter.
  • Hudson Bay Capital Management sold 3,763 Arcadia Biosciences shares in Q2 2018, an estimated $4.14M.
  • Hudson Bay Capital Management first reported a position in Arcadia Biosciences in Q1 2018 and held it in 1 quarter.
  • Hudson Bay Capital Management's Arcadia Biosciences position peaked at $4.14M in Q1 2018.
  • 13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2018.

Based on Hudson Bay Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.